JFK Hospital introduces innovative brain tumor treatment
New therapy is shown to slow brain tumor progression.
In a pioneering move, HCA Florida JFK Hospital is now offering GammaTile® Therapy, an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT), for brain tumors. Neurosurgeon, Dr. Yehuda Herschman, and radiation oncologists Dr. Georges Hatoum, and Dr. Silvio Garcia successfully performed the first treatment on a patient in Palm Beach County earlier this month.
GammaTile Therapy, a cutting-edge approach to treating aggressive brain tumors, aims to delay tumor regrowth while safeguarding healthy brain tissue. "I am excited to offer this new treatment for brain tumor patients and look forward to partnering with local physicians for those who may be good candidates for this treatment," expressed Dr. Herschman.
With over 200,000 annual diagnoses of aggressive brain tumors in the U.S., this surgically treated radiation therapy addresses the challenge of recurrence in resistant tumors. The FDA-cleared treatment is suitable for newly diagnosed malignant brain tumors, recurrent gliomas, glioblastomas, meningiomas, and brain metastases.
The postage-stamp-sized tile, embedded with small radiation sources, is implanted during brain tumor removal surgery, immediately targeting potential recurrence areas. This novel treatment improves local tumor control, potentially extending patients' lives.
"We are proud to be the first in Palm Beach County to offer this innovative technique, providing new alternatives for patients fighting brain cancer," remarked Dr. Hatoum.
Traditionally, patients with operable brain tumors undergo surgery followed by adjuvant therapy involving radiation and chemotherapy. This type of radiation therapy revolutionizes this by delivering targeted treatment over time, allowing patients to maintain their daily lives. The highly focused approach minimizes damage to healthy tissue, reducing side effects like hair loss.
Ken West, CEO of HCA Florida JFK Hospital, stated, "I am proud to lead a team of dedicated professionals, where we are committed to pioneering advancements in healthcare. The introduction of GammaTile® Therapy reflects our dedication to providing innovative treatments for brain tumor patients, offering hope and extending lives. We look forward to continued collaboration with local physicians to benefit our community."